IQVIA Holdings reported $197M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Accenture USD 70.64M 7.08M Mar/2026
Agilent USD 25M 0 Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Cardinal Health USD 101M 13M Mar/2026
Celltrion KRW 19B 1.96B Jun/2025
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Cigna USD 157.08B 3.82B Jun/2026
Cognizant Technology Solutions USD 13M 6M Jun/2026
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
CVS Health USD 757M 17M Jun/2026
Danaher USD 107M 44M Jun/2026
Dentsply International USD 24M 2M Mar/2026
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Jun/2026
Elevance Health USD 364M 7M Jun/2026
Humana USD 197M 4M Jun/2026
IBM USD 473M 5M Mar/2026
Illumina USD 24M 2M Mar/2026
Infosys INR 1.05B 50M Mar/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Laboratory Of America USD 61.1M 6M Jun/2026
McKesson USD 77M 18M Jun/2026
Mettler Toledo International USD 17.25M 239K Jun/2026
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Publicis EUR 51M 10M Jun/2025
Qiagen NV USD 11.05M 912K Mar/2026
Quest Diagnostics USD 69M 2M Sep/2025
Revvity USD 22.99M 1.73M Jun/2026
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
UnitedHealth USD 962M 7M Jun/2026
Veeva Systems USD 65.1M 8.4M Mar/2025
Veradigm USD 1.25M 641K Sep/2022
Waters USD 55M 13M Jun/2026
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025